Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer

References

• Ward RM, Bristow RE. Cancer and pregnancy: recent developments. Curr Opin Obstet Gynecol. 2002;14:613–7.
   PubMed Web of Science ®Google Scholar
• Gadducci A, Cosio S, Fanucchi A, et al. Chemotherapy with epirubicin and paclitaxel for breast cancer during pregnancy: case report and review of the literature. Anticancer Res. 2003;23:5225–5229.
   PubMed Web of Science ®Google Scholar
• Rizack T, Mega A, Legare R, et al. Management of hematological malignancies during pregnancy. Am J Hematol. 2009;84:830–841.
   PubMed Web of Science ®Google Scholar
• Mir O, Berveiller P, Rouzier R, et al. Chemotherapy for breast cancer during pregnancy: is epirubicin safe? Ann Oncol. 2008;19:1814–1815.
   PubMed Web of Science ®Google Scholar
• Loibl S, Schmidt A, Gentilini O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol. 2015;1:1145–5.
   PubMed Web of Science ®Google Scholar
• Pacifici GM, Nottoli R. Placental transfer of drugs administered to the mother. Clin Pharmacokinet. 1995;28:235–69.
   PubMed Web of Science ®Google Scholar
• Mir O, Berveiller P, Goffinet F, et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol. 2010;21:425–426.
   PubMed Web of Science ®Google Scholar
• Amant F, Halaska MJ, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014;24:394–403.
   PubMed Web of Science ®Google Scholar
• Mir O, Berveiller P, Ropert S, et al. Use of platinum derivatives during pregnancy. Cancer. 2008;113:3069–3074.
   PubMed Web of Science ®Google Scholar
• Zagouri F, Sergentanis TN, Chrysikos D, et al. Trastuzumab administration during pregnancy: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;137:349–357.
   PubMed Web of Science ®Google Scholar
• Schur S, Wild J, Amann G, et al. Sarcoma of the ewing family in pregnancy: a case report of intrauterine fetal death after induction of chemotherapy. Case Rep Oncol. 2012;5:633–638.
   PubMedGoogle Scholar
• Siepermann M, Koscielniak E, Dantonello T, et al. Oral low-dose chemotherapy: successful treatment of an alveolar rhabdomyosarcoma during pregnancy. Pediatr Blood Cancer. 2012;58:104–106.
   PubMed Web of Science ®Google Scholar
• Shieh MP, Mehta RS. Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy. Ann Oncol. 2011;22:2151–2152.
   PubMed Web of Science ®Google Scholar
• Ledermann JA, Raja FA, Fotopoulou C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi24–32.
   PubMed Web of Science ®Google Scholar
• Chatelut E, Canal P, Brunner V, et al. Prediction of carboplatin clearance from standard morphological and biological patient characteristics. J Natl Cancer Inst. 1995;87:573–580.
   PubMed Web of Science ®Google Scholar
• Viana LS, Tsunoda AT, Nunes JS, et al. Preservation of pregnancy in a patient with acute abdominal pain secondary to advanced and hemorrhagic yolk sac tumor of the right ovary. J Clin Oncol. 2011;29:e758–62.
   PubMed Web of Science ®Google Scholar
• Ratain MJ, Rowley JD. Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: from the bedside to the target genes. Ann Oncol. 1992;3:107–111.
   PubMed Web of Science ®Google Scholar
• Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer. 1991;68:600–604.
   PubMed Web of Science ®Google Scholar
• Group ESESNW. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):iii102–12.
   PubMed Web of Science ®Google Scholar
• Mir O, Berrada N, Domont J, et al. Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy. Cancer Chemother Pharmacol. 2012;69:357–367.
   PubMed Web of Science ®Google Scholar
• Pasternak B, Svanstrom H, Molgaard-Nielsen D, et al. Metoclopramide in pregnancy and risk of major congenital malformations and fetal death. JAMA. 2013;310:1601–1611.
   PubMed Web of Science ®Google Scholar
• Pasternak B, Svanstrom H, Hviid A. Ondansetron in pregnancy and risk of adverse fetal outcomes. N Engl J Med. 2013;368:814–823.
   PubMed Web of Science ®Google Scholar
• Yost NP, McIntire DD, Wians FH Jr., et al. A randomized, placebo-controlled trial of corticosteroids for hyperemesis due to pregnancy. Obstet Gynecol. 2003;102:1250–1254.
   PubMed Web of Science ®Google Scholar
• Tan PC, Omar SZ. Contemporary approaches to hyperemesis during pregnancy. Curr Opin Obstet Gynecol. 2011;23:87–93.
   PubMed Web of Science ®Google Scholar
• Dale DC, Cottle TE, Fier CJ, et al. severe chronic neutropenia: treatment and follow-up of patients in the severe chronic neutropenia international registry. Am J Hematol. 2003;72:82–93.
   PubMed Web of Science ®Google Scholar
• Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Hum Reprod. 2009;24:2703–2708.
   PubMed Web of Science ®Google Scholar
• Van Hasselt JG, Van Calsteren K, Heyns L, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol. 2014;25:2059–65.
   PubMed Web of Science ®Google Scholar
• D’Incalci M, Sessa C, Colombo N, et al. Transplacental passage of cyclophosphamide. Cancer Treat Rep. 1982;66:1681–1682.
   PubMedGoogle Scholar
• Van Calsteren K, Verbesselt R, Beijnen J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol. 2010;119:594–600.
   PubMed Web of Science ®Google Scholar
• Elit L, Bocking A, Kenyon C, et al. An endodermal sinus tumor diagnosed in pregnancy: case report and review of the literature. Gynecol Oncol. 1999;72:123–127.
   PubMed Web of Science ®Google Scholar
• Arango HA, Kalter CS, Decesare SL, et al. Management of chemotherapy in a pregnancy complicated by a large neuroblastoma. Obstet Gynecol. 1994;84:665–668.
   PubMedGoogle Scholar
• Koc ON, McFee M, Reed E, et al.. Detection of platinum-DNA adducts in cord blood lymphocytes following in utero platinum exposure. Eur J Cancer. 1994;30A:716–7.
   PubMed Web of Science ®Google Scholar
• Marnitz S, Schmittel A, Bolbrinker J, et al. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum. Fertil Steril. 2009;92(1748):e1741–4.
   Google Scholar
• Nekhayeva IA, Nanovskaya TN, Hankins GD, et al. Role of human placental efflux transporter P-glycoprotein in the transfer of buprenorphine, levo-alpha-acetylmethadol, and paclitaxel. Am J Perinatol. 2006;23:423–430.
   PubMed Web of Science ®Google Scholar
• Cardonick E, Bhat A, Gilmandyar D, et al. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann Oncol. 2012;23:3016–3023.
   PubMed Web of Science ®Google Scholar
• Smith JA, Gaikwad A, Mosley S, et al. Utilization of an ex vivo human placental perfusion model to predict potential fetal exposure to carboplatin during pregnancy. Am J Obstet Gynecol. 2014;210: 275;e271–9.
   Web of Science ®Google Scholar
• Kopf-Maier P. Stage of pregnancy-dependent transplacental passage of 195mPt after cis-platinum treatment. Eur J Cancer Clin Oncol. 1983;19:533–536.
   PubMedGoogle Scholar
• Karp GI, Von Oeyen P, Valone F, et al. Doxorubicin in pregnancy: possible transplacental passage. Cancer Treat Rep. 1983;67:773–777.
   PubMedGoogle Scholar
• Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet. 2004;43:487–514.
   PubMed Web of Science ®Google Scholar
• Gedeon C, Koren G. Designing pregnancy centered medications: drugs which do not cross the human placenta. Placenta. 2006;27:861–868.
   PubMed Web of Science ®Google Scholar
• Pirani BB, Campbell DM, MacGillivray I. Plasma volume in normal first pregnancy. J Obstet Gynaecol Br Commonw. 1973;80:884–887.
   PubMedGoogle Scholar
• Krauer B, Dayer P, Anner R. Changes in serum albumin and alpha 1-acid glycoprotein concentrations during pregnancy: an analysis of fetal-maternal pairs. Br J Obstet Gynaecol. 1984;91:875–881.
   PubMedGoogle Scholar
• Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet. 2005;44:989–1008.
   PubMed Web of Science ®Google Scholar
• Schneider H, Panigel M, Dancis J. Transfer across the perfused human placenta of antipyrine, sodium and leucine. Am J Obstet Gynecol. 1972;114:822–8.
   PubMed Web of Science ®Google Scholar
• Colombo N, Carinelli S, Colombo A, et al. Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii27–32.
   PubMedGoogle Scholar
• Colombo N, Peiretti M, Garbi A, et al. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23(Suppl 7):vii20–26.
   PubMed Web of Science ®Google Scholar
• Cardonick E, Gilmandyar D, Somer RA. Maternal and neonatal outcomes of dose-dense chemotherapy for breast cancer in pregnancy. Obstet Gynecol. 2012;120:1267–1272.
   PubMed Web of Science ®Google Scholar
• Mir O, Durand JP, Boudou-Rouquette P, et al. Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study. Support Care Cancer. 2012;20:2235–2239.
   PubMed Web of Science ®Google Scholar
• Henderson CE, Elia G, Garfinkel D, et al. Platinum chemotherapy during pregnancy for serous cystadenocarcinoma of the ovary. Gynecol Oncol. 1993;49:92–94.
   PubMed Web of Science ®Google Scholar
• Kohler C, Oppelt P, Favero G, et al. How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am J Obstet Gynecol. 2015;213:206.e1–5.
   Web of Science ®Google Scholar
• Al-Saleh E, Al-Harmi J, Nandakumaran M, et al. Transport kinetics of cisplatin in the perfused human placental lobule in vitro. J Matern Fetal Neonatal Med. 2008;21:726–731.
   PubMed Web of Science ®Google Scholar
• Calsteren KV, Verbesselt R, Devlieger R, et al. Transplacental transfer of paclitaxel, docetaxel, carboplatin, and trastuzumab in a baboon model. Int J Gynecol Cancer. 2010;20:1456–1464.
   PubMed Web of Science ®Google Scholar
• Esumi Y, Mitsugi K, Seki H, et al. Placental transfer, lacteal transfer and plasma protein binding of gemcitabine. Xenobiotica. 1994;24:957–964.
   PubMed Web of Science ®Google Scholar
• Willemse PH, van der Sijde R, Sleijfer DT. Combination chemotherapy and radiation for stage IV breast cancer during pregnancy. Gynecol Oncol. 1990;36:281–284.
   PubMed Web of Science ®Google Scholar
• Barni S, Ardizzoia A, Zanetta G, et al. Weekly doxorubicin chemotherapy for breast cancer in pregnancy. A Case Report Tumori. 1992;78:349–350.
   Google Scholar
• Roboz J, Gleicher N, Wu K, et al. Does doxorubicin cross the placenta? Lancet. 1979;2:1382–1383.
   PubMed Web of Science ®Google Scholar
• d’Incalci M, Broggini M, Buscaglia M, et al.. Transplacental passage of doxorubicin. Lancet. 1983;1:75.
   PubMed Web of Science ®Google Scholar
• Soininen SK, Repo JK, Karttunen V, et al. Human placental cell and tissue uptake of doxorubicin and its liposomal formulations. Toxicol Lett. 2015;239:108–114.
   PubMed Web of Science ®Google Scholar
• Grohard P, Akbaraly JP, Saux MC, et al. Transplacental passage of doxorubicin. J Gynecol Obstet Biol Reprod (Paris). 1989;18:595–600.
   PubMedGoogle Scholar
• Van Calsteren K, Hartmann D, Van Aerschot L, et al. Vinblastine and doxorubicin administration to pregnant mice affects brain development and behaviour in the offspring. Neurotoxicology. 2009;30:647–657.
   PubMed Web of Science ®Google Scholar
• Van Calsteren K, Verbesselt R, Van Bree R, et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model. Reprod Sci. 2011;18:57–63.
   PubMed Web of Science ®Google Scholar
• Jonker JW, Smit JW, Brinkhuis RF, et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst. 2000;92:1651–1656.
   PubMed Web of Science ®Google Scholar
• Yamauchi H, Katayama K, Ueno M, et al. Etoposide induces TRP53-dependent apoptosis and TRP53-independent cell cycle arrest in trophoblasts of the developing mouse placenta. Biol Reprod. 2009;80:813–822.
   PubMed Web of Science ®Google Scholar
• Ghaemmaghami F, Abbasi F, Abadi AG. A favorable maternal and neonatal outcome following chemotherapy with etoposide, bleomycin, and cisplatin for management of grade 3 immature teratoma of the ovary. J Gynecol Oncol. 2009;20:257–259.
   PubMed Web of Science ®Google Scholar
• Han JY, Nava-Ocampo AA, Kim TJ, et al. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases. Reprod Toxicol. 2005;19:557–561.
   PubMed Web of Science ®Google Scholar
• Avastin (Bevacizumab). European Medicines Agency. [Cited 2015 october 10]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000582/human_med_000663.jsp&mid=WC0b01ac058001d124.
   Google Scholar
• Simister NE. Placental transport of immunoglobulin G. Vaccine. 2003;21:3365–3369.
   PubMed Web of Science ®Google Scholar
• Thorn M, Piche-Nicholas N, Stedman D, et al. Embryo-fetal transfer of bevacizumab (Avastin) in the rat over the course of gestation and the impact of neonatal Fc receptor (FcRn) binding. Birth Defects Res B Dev Reprod Toxicol. 2012;95:363–375.
   PubMed Web of Science ®Google Scholar
• Kaygusuz I, Eser A, Inegol Gumus I, et al. Effect of anti-vascular endothelial growth factor antibody during early fetal development in rats. J Matern Fetal Neonatal Med. 2014;27:1744–1748.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111:649–658.
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab. 2003;88:5555–5563.
   PubMed Web of Science ®Google Scholar
• Nanovskaya T, Nekhayeva I, Karunaratne N, et al. Role of P-glycoprotein in transplacental transfer of methadone. Biochem Pharmacol. 2005;69:1869–1878.
   PubMed Web of Science ®Google Scholar
• Berveiller P, Vinot C, Mir O, et al. Comparative transplacental transfer of taxanes using the human perfused cotyledon placental model. Am J Obstet Gynecol. 2012;207(514):e511–514 e517.
   PubMed Web of Science ®Google Scholar
• Laberge RM, Ambadipudi R, Georges E. P-glycoprotein (ABCB1) modulates collateral sensitivity of a multidrug resistant cell line to verapamil. Arch Biochem Biophys. 2009;491:53–60.
   PubMed Web of Science ®Google Scholar
• Balimane PV, Chong S. A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay. Int J Pharm. 2005;301:80–88.
   PubMed Web of Science ®Google Scholar
• Sudhakaran S, Rayner CR, Li J, et al. Inhibition of placental P-glycoprotein: impact on indinavir transfer to the foetus. Br J Clin Pharmacol. 2008;65:667–673.
   PubMed Web of Science ®Google Scholar
• Kolwankar D, Glover DD, Ware JA, et al. Expression and function of ABCB1 and ABCG2 in human placental tissue. Drug Metab Dispos. 2005;33:524–529.
   PubMed Web of Science ®Google Scholar
• Ushigome F, Koyabu N, Satoh S, et al. Kinetic analysis of P-glycoprotein-mediated transport by using normal human placental brush-border membrane vesicles. Pharm Res. 2003;20:38–44.
   PubMed Web of Science ®Google Scholar